Literature DB >> 10190362

Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients.

G B Doglietto1, F Pacelli, P Caprino, S Alfieri, C Carriero, M Malerba, F Crucitti.   

Abstract

Few reports of the Western countries have investigated the value of palliative surgery for stomach cancer. The aim of this study was to evaluate the results of palliative surgery in a large series of patients affected by gastric carcinoma, consecutively treated by the same surgical team. The hospital records of 305 patients affected by gastric cancer who did not undergo surgical treatment or who underwent a palliative surgical procedure at our unit between 1981 and 1995 were reviewed. Univariate and multivariate analyses were used to calculate the 5-year survival probabilities with respect to the following variables: demographic data, tumor location and gross appearance, spread of the disease, histological type according to P. Lauren, and type of treatment. Multivariate logistic regression analysis showed that resectional surgery and tumor spread limited to local sites were independently associated with better survival. The study indicates that even though there are host-related factors that govern survival in far-advanced stomach cancer, the type of surgery can have a significant effect on prognosis; resectional surgery should be undertaken whenever possible in such patients.

Entities:  

Mesh:

Year:  1999        PMID: 10190362

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  11 in total

Review 1.  Surgical palliation in advanced disease: recent developments.

Authors:  Geoffrey P Dunn
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

Review 2.  A systematic review of surgery for non-curative gastric cancer.

Authors:  Alyson L Mahar; Natalie G Coburn; Simron Singh; Calvin Law; Lucy K Helyer
Journal:  Gastric Cancer       Date:  2011-10-28       Impact factor: 7.370

3.  A life-saving but inadequately discussed procedure: tube duodenostomy. Known and unknown aspects.

Authors:  Burak Isik; Sezai Yilmaz; Vedat Kirimlioglu; Gokhan Sogutlu; Mehmet Yilmaz; Daniel Katz
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

4.  Role of metastasectomy on overall survival of patients with metastatic gastric cancer.

Authors:  Seung Wook Yang; Min Gyu Kim; Ju Hee Lee; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2013-12-31       Impact factor: 3.720

5.  Palliative gastrectomy and chemotherapy for stage IV gastric cancer.

Authors:  Sheng-Zhang Lin; Hong-Fei Tong; Tao You; Yao-Jun Yu; Wei-Jun Wu; Cong Chen; Wei Zhang; Bing Ye; Chun-Ming Li; Zhi-Qiang Zhen; Jia-Rong Xu; Jun-Liang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

6.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

7.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-01-28       Impact factor: 0.656

8.  Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study.

Authors:  Xingkang He; Sanchuan Lai; Tingting Su; Yangyang Liu; Yue Ding; Sheng Quan; Jianmin Si; Leimin Sun
Journal:  Oncotarget       Date:  2017-11-20

9.  Surgical Outcomes and Survival Prognostic Factors for Palliative Gastrectomies in Stage IV Resectable Gastric Cancer Outlet Obstruction Patients.

Authors:  Won Yong Choi; Hyun Il Kim; Seong Ho Park; Jong Hoon Yeom; Woo Jae Jeon; Min Gyu Kim
Journal:  J Gastric Cancer       Date:  2020-12-23       Impact factor: 3.720

10.  Non-curative surgery for patients with gastric cancer with local peritoneal metastasis: A retrospective cohort study.

Authors:  Yuanqiang Dong; Shulan Ma; Shuo Yang; Fen Luo; Zhiming Wang; Fenghua Guo
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.